OptiBiotix Health PLC OPTBF
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- $0.00 / —
- Shares Outstanding
- 103.30M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 7.78
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
OptiBiotix Health PLC principal activity is that of identifying and developing microbial strains, compounds, and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health benefits. It is a life sciences business focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. Its product portfolio includes First-generation products- SlimBiome, WellBiome; and Second-generation solutions- SweetBiotix, Microbiome Modulators. The group has one class of business. It has presence in United Kingdom, United States, India China, and Rest of world. The company generates majority of revenue from United States.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 9
- Website
- https://www.optibiotix.com
Valuation
|
Metric
|
OPTBF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.08 |
Price/Sales | 7.78 |
Price/Cash Flow | — |
Price/Earnings
OPTBF
Financial Strength
|
Metric
|
OPTBF
|
|---|---|
Quick Ratio | 3.49 |
Current Ratio | 4.27 |
Interest Coverage | — |
Quick Ratio
OPTBF
Profitability
|
Metric
|
OPTBF
|
|---|---|
Return on Assets (Normalized) | −29.35% |
Return on Equity (Normalized) | −35.38% |
Return on Invested Capital (Normalized) | −31.88% |
Return on Assets
OPTBF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|@rlpB<C | LOCK|ll#z! | $126B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|>!n?&%W | LOCK|Lwz> | $81B | |||
| argenx SE ADR
ARGX
| LOCK|G@CXhc | LOCK|<kj | $55B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|J^$<#Ld | LOCK|T#<t$ | $50B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|><S>>Bc | LOCK|># | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|C^tqThm | LOCK|d!mH | $29B | |||
| Incyte Corp
INCY
| LOCK|!ngG#K | LOCK|DF | $24B | |||
| Moderna Inc
MRNA
| LOCK|#XSVXNp | LOCK|sY# | $24B | |||
| BioNTech SE ADR
BNTX
| LOCK|^hzk<c | LOCK|Wj | $24B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|j!>!wH# | LOCK|t< | $17B |
United States